ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 85

Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach

Janet Roberts1, Stephanie O. Keeling2 and Steven J. Katz3, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Rheumatology, University of Alberta, Edmonton, AB, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: interdisciplinary rheumatology team

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Health Services Research - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The University of Alberta Division of Rheumatology has launched a new multidisciplinary clinic, the On-TRACC Program (On Treating Rheumatoid Arthritis – Providing Access to Care), which provides aggressive treat to target (T2T) disease modification and co-morbidity management in a shared-care model of rheumatologists and advanced care practitioners (ACP). Primary Objective: To evaluate patient satisfaction in patients enrolled in the On-TRACC program compared to those treated in general rheumatology clinics through a patient satisfaction survey.

Methods: We performed an observational cross-sectional survey study using a modified version of the Leeds Satisfaction Questionnaire (LSQ), a validated and reliable tool developed for inflammatory arthritis (IA) outpatient clinics, to compare satisfaction between the two patient groups: On-TRAAC and the traditional model of care (TMC). The six groups included in the questionnaire’s subscales, and thus assessed with this survey included: (1) provision of information, (2) empathy with the patient, (3) attitude towards the patient, (4) access to and continuity with the caregiver, (5) technical competence and (6) overall satisfaction. A sub-group analysis of patient satisfaction between the first and second visit in the On-TRACC group was also performed. Markers of disease activity including DAS 28-CRP, HAQ (Health Assessment Questionnaire) and CRP were assessed over time in the On-TRACC group.

Results: A total of 75 patients completed the survey (27 patients in the On-TRAAC group and 48 in the TMC). The average age of the participants was 53 years and included 24 males and 51 females. The overall satisfaction score was 4.36 in the TMC group and 4.48 in the On-TRAAC group (higher values represents higher satisfaction). Ten patients in the On-TRAAC group performed the survey at least twice and showed an overall trend towards improved satisfaction on subsequent visits with an initial overall satisfaction score of 4.48 and follow up score of 4.55. No statistically significant differences were noted between groups, or within the On-TRACC group. Within the On-TRACC group, markers of disease activity including DAS 28 CRP, HAQ and CRP all showed improvement between baseline and follow-up visits.

Conclusion: While patients in both treatment groups were very satisfied with their care, patients in the On-TRACC group were at least as satisfied with their care as those in the TMC, and there was a trend towards improved satisfaction with the multi-disciplinary care model. This has important implications as it lends support to the use of this alternate model of care in the provision of services to those with IA, which has potential benefits from both a clinical and health economics perspective. Larger patient numbers with longer follow-up are needed to provide meaningful comparisons between these different models of care. Table 1. Baseline characteristics and overall satisfaction

Characteristic On Tracc Group (n=27) TMC (n=48)
Mean age (Range) ± SD 50.6 years (22-85) ± 16.63 54.4 years (18-87) ± 16.39
Gender 6 Male (22%) 21 Female (78%) 18 Male (37.5%) 30 Female (62.5)
Duration of Inflammatory Arthritis < 1 year = 8 (30%) 1-5 years = 6 (22%) > 5 years = 13 (48%) < 1 year = 6 (12.5%) 1-5 years = 22 (46%) > 5 years = 20 (41.5%)
Ethnic Origin 22 Caucasian (81%) 2 Asian (7.5%) 2 First nations (7.5%) 1 Mixed ethnicity (4%) Unknown
Smoking Status 2 Current smokers (7%) 8 Ex-smokers (30%) 17 Never smokers (63%) Unknown
Baseline CRP 5 patients < 1 (19%) 20 patients > 1 (74%) Unknown
Baseline DAS 28 CRP 10 patients < 2.6 (37%) 15 patients > 2.6 (56%) Unknown
Overall Satisfaction 4.48 4.36

Disclosure: J. Roberts, None; S. O. Keeling, None; S. J. Katz, None.

To cite this abstract in AMA style:

Roberts J, Keeling SO, Katz SJ. Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-patient-satisfaction-with-the-on-tracc-program-benefits-of-a-joint-approach/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-patient-satisfaction-with-the-on-tracc-program-benefits-of-a-joint-approach/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology